跳至主要内容
临床试验/RBR-36byz5
RBR-36byz5招募中未知

The use of probiotic L. plantarum in dyslipidemia in children and adolescents with nephrotic syndrome: a double-blind, randomized, placebo-controlled clinical trial

Patrícia Marques Fortes0 个研究点开始时间: 2017年1月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Intervention

入排标准

年龄范围
2Y 至 17Y(—)

入选标准

  • Cases and controls: individuals 2-17 years and 11 months; of both sexes in regular outpatient follow-up for at least 1 year and that have in the last three months:24h proteinuria less than 50 mg / kg / day or 40 mg / m² of body surface area (BSA)Serum Albumin > 2.0 g / dl;
  • total cholesterol > 170 mg / dl and / or triglyceride levels > 130 mg / dl; preserved renal function (glomerular filtration rate > 60ml / min); in corticoids (prednisone < 1mg / kg / day) and / or cyclosporin 5mg / kg / day; not in use of statins,do not have infectious processes at the time of selection; have not presented clinical or laboratory decompensated SN less than 3 months.

排除标准

  • Individuals with kidney disease from stage III; pregnant women; cancer patients; acquired immunodeficiency syndrome, hypothyroidism, metabolic disease; severe cardiovascular disease; cerebrovascular diseas; symptomatic heart failure; viral or bacterial infectious diseases.

研究者

发起方
Patrícia Marques Fortes

相似试验